BioLineRx Highlights Presentation Of Data From From Triple Combination Of BL-8040 Anti PD-1 And Chemotherapy Demonstrating 'Significant Reduction in Pancreatic Tumor Growth and Favorable Changes in Tumor Microenvironment'